Pathogen-Reduction for Platelet Concentrates

被引:0
作者
Weber, C. F. [1 ]
Heim, M. U. [2 ]
机构
[1] Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany
[2] Otto von Guericke Univ Hosp, Inst Transfus Med & Immunohematol, Magdeburg, Germany
关键词
FUNCTIONAL-CHARACTERISTICS; THERAPEUTIC-EFFICACY; APHERESIS PLATELETS; TREATED PLATELETS; SPRINT TRIAL; INACTIVATION; SAFETY; LIGHT; ULTRAVIOLET; TECHNOLOGY;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:293 / 295
页数:3
相关论文
共 50 条
[21]   Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review [J].
Tsalas, Stavros ;
Petrou, Eleni ;
Tsantes, Andreas G. ;
Sokou, Rozeta ;
Loukopoulou, Electra ;
Houhoula, Dimitra ;
Mantzios, Petros G. ;
Kriebardis, Anastasios G. ;
Tsantes, Argirios E. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2023, 49 (05) :523-541
[22]   Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling [J].
Reid, Samantha ;
Johnson, Lacey ;
Woodland, Narelle ;
Marks, Denese C. .
TRANSFUSION, 2012, 52 (10) :2094-2103
[23]   A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light [J].
Mohr, Harald ;
Steil, Leif ;
Gravemann, Ute ;
Thiele, Thomas ;
Hammer, Elke ;
Greinacher, Andreas ;
Mueller, Thomas H. ;
Voelker, Uwe .
TRANSFUSION, 2009, 49 (12) :2612-2624
[24]   Platelet microRNA Profiles and the Effect of Pathogen Reduction on Platelet Function [J].
Hitzler, W. ;
Vamvakas, E. C. .
CLINICAL LABORATORY, 2011, 57 (7-8) :451-454
[25]   Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency [J].
Focosi, D. ;
Franchini, M. .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (02) :132-134
[26]   Pathogen-reduction technology, good in more than one way for cellular blood components, is replacing irradiation [J].
Flegel, Willy Albert .
TRANSFUSION AND APHERESIS SCIENCE, 2025, 64 (02)
[27]   Platelet Additive Solutions and Pathogen Reduction Impact on Transfusion Safety, Patient Management and Platelet Supply [J].
Andreu, Georges ;
Boudjedir, Karim ;
Meyer, Nicolas ;
Carlier, Monique ;
Drouet, Christian ;
Py, Jean-Yves ;
Tacquard, Charles ;
Mertes, Paul Michel ;
Sandid, Imad .
TRANSFUSION MEDICINE REVIEWS, 2025, 39 (01)
[28]   Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates [J].
Stanojkovic, Zoran ;
Antic, Ana ;
Stojanovic, Miodrag .
VOJNOSANITETSKI PREGLED, 2011, 68 (06) :489-494
[29]   Molecular validation of pathogen-reduction technologies using rolling-circle amplification coupled with real-time PCR for torquetenovirus DNA quantification [J].
Focosi, Daniele ;
Macera, Lisa ;
Spezia, Pietro Giorgio ;
Ceccarelli, Francesca ;
Lanza, Maria ;
Maggi, Fabrizio .
TRANSFUSION MEDICINE, 2021, 31 (05) :371-376
[30]   Swiss Haemovigilance data for pathogen inactivated and conventional platelet concentrates [J].
Mansouri-Taleghani, B. ;
Jutzi, M. P. ;
Rueesch, M. .
ONKOLOGIE, 2012, 35 :222-223